Wave 80 Biosciences Inc - Product Pipeline Analysis, 2018 Update

Wave 80 Biosciences Inc - Product Pipeline Analysis, 2018 Update


  • Products Id :- GDME271493PD
  • |
  • Pages: 28
  • |
  • |
  • |
  Request for Sample Report
  Request A Quote

Executive Summary

Summary

Wave 80 Biosciences Inc (Wave 80) is a medical device company that develops molecular diagnostic instruments and consumables. The company develops molecular diagnostics instruments for chlamydia, respiratory illness, cancers, autoimmune diseases, hepatitis B, hepatitis C, HIV/AIDS and other human health conditions. It provides EOSCAPE molecular diagnostics technology that facilitates provision of molecular testing in smaller hospitals and clinics. Wave 80 provides EOSCAPE-HIV, an in vitro nucleic acid assay, which enables the detection and quantitation of human immunodeficiency virus type 1 (HIV-1) RNA. The company's pipeline comprises assays for infectious and non-infectious diseases such as EOSCAPE-HBV DNA, EOSCAPE-HIV RNA PLUS, EOSCAPE-TB, EOSCAPE-TB-DST, and others. It caters to the clinical laboratory testing system markets. Wave 80 is headquartered in San Francisco, California, the US.

This report is a source for data, analysis, and actionable intelligence on the company's portfolio of pipeline products. The report provides key information about the company, its major products and brands.

The report enhances decision making capabilities and help to create effective counter strategies to gain competitive advantage.

Scope:

- The report reviews detailed company profile with information on business description, key company facts, major products and services, key competitors, key employees, locations and subsidiaries and recent developments

- The report analyzes all pipeline products in development for the company Wave 80 Biosciences Inc

- The report provides pipeline analysis on all pipeline products of the company (by equipment type, by indication, by development stage, and by trial status)

- The report covers detailed information on each pipeline product with information on pipeline territory, stage of development, device class, regulatory path, indication(s), application(s) and estimated launch date

- The report provides detailed description of products in development, technical specification and functions

- The report also covers ongoing clinical trials (wherever applicable) with information on trial name, trial objective, sponsor, trial design , trial status and phase, estimated start and end date.

Reasons to buy:

- Develop business strategies by understanding the trends and developments driving the medical devices pipeline and technology landscape

- Design and develop your product development, marketing and sales strategies by understanding the competitor portfolio

- To formulate effective Research & Development strategies

- Develop market-entry and market expansion strategies

- Exploit in-licensing and out-licensing opportunities by identifying products, most likely to ensure a robust return

- Plan mergers and acquisitions effectively by identifying key players of the most promising pipeline

- Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage

- Develop competition strategies by identifying the status and likely launch of the competitors' pipeline products through review of the clinical trials, stage and of development, etc

- Identify, understand and capitalize the next high-value products that your competitor would add in its portfolio

Note: Some sections may be missing if data is unavailable for the company



Read More



Contact Us:
Ken Research
Ankur Gupta, Head Marketing & Communications

+91-9015378249

Table of Contents

Table of Contents 2

List of Tables 3

List of Figures 3

Wave 80 Biosciences Inc Company Overview 4

Wave 80 Biosciences Inc Company Snapshot 4

Wave 80 Biosciences Inc Pipeline Products and Ongoing Clinical Trials Overview 4

Wave 80 Biosciences Inc-Pipeline Analysis Overview 7

Wave 80 Biosciences Inc-Key Facts 7

Wave 80 Biosciences Inc-Major Products and Services 8

Wave 80 Biosciences Inc Pipeline Products by Development Stage 9

Wave 80 Biosciences Inc Pipeline Products Overview 11

Diagnostic Test-Liver Cancer 11

Diagnostic Test-Liver Cancer Product Overview 11

EOSCAPE HIV-1 RNA Viral Load Test 12

EOSCAPE HIV-1 RNA Viral Load Test Product Overview 12

EOSCAPE-HBV DNA 13

EOSCAPE-HBV DNA Product Overview 13

EOSCAPE-HBV DNA PLUS 14

EOSCAPE-HBV DNA PLUS Product Overview 14

EOSCAPE-HCV RNA 15

EOSCAPE-HCV RNA Product Overview 15

EOSCAPE-HIV RNA PLUS 16

EOSCAPE-HIV RNA PLUS Product Overview 16

EOSCAPE-STD 17

EOSCAPE-STD Product Overview 17

EOSCAPE-T1D 18

EOSCAPE-T1D Product Overview 18

EOSCAPE-TB 19

EOSCAPE-TB Product Overview 19

EOSCAPE-TB-DST 20

EOSCAPE-TB-DST Product Overview 20

Integrated Diagnostic System-Influenza A 21

Integrated Diagnostic System-Influenza A Product Overview 21

Wave 80 Biosciences Inc-Key Competitors 22

Wave 80 Biosciences Inc-Key Employees 23

Wave 80 Biosciences Inc-Locations And Subsidiaries 24

Head Office 24

Appendix 25

Methodology 25

About GlobalData 28

Contact Us 28

Disclaimer 28

List of Figures

Wave 80 Biosciences Inc Pipeline Products by Equipment Type 5

Wave 80 Biosciences Inc Pipeline Products by Development Stage 9

List of Tables

Wave 80 Biosciences Inc Pipeline Products and Ongoing Clinical Trials Overview 4

Wave 80 Biosciences Inc Pipeline Products by Equipment Type 5

Wave 80 Biosciences Inc Pipeline Products by Indication 6

Wave 80 Biosciences Inc, Key Facts 7

Wave 80 Biosciences Inc, Major Products and Services 8

Wave 80 Biosciences Inc Number of Pipeline Products by Development Stage 9

Wave 80 Biosciences Inc Pipeline Products Summary by Development Stage 10

Diagnostic Test-Liver Cancer-Product Status 11

Diagnostic Test-Liver Cancer-Product Description 11

EOSCAPE HIV-1 RNA Viral Load Test-Product Status 12

EOSCAPE HIV-1 RNA Viral Load Test-Product Description 12

EOSCAPE-HBV DNA-Product Status 13

EOSCAPE-HBV DNA-Product Description 13

EOSCAPE-HBV DNA PLUS-Product Status 14

EOSCAPE-HBV DNA PLUS-Product Description 14

EOSCAPE-HCV RNA-Product Status 15

EOSCAPE-HCV RNA-Product Description 15

EOSCAPE-HIV RNA PLUS-Product Status 16

EOSCAPE-HIV RNA PLUS-Product Description 16

EOSCAPE-STD-Product Status 17

EOSCAPE-STD-Product Description 17

EOSCAPE-T1D-Product Status 18

EOSCAPE-T1D-Product Description 18

EOSCAPE-TB-Product Status 19

EOSCAPE-TB-Product Description 19

EOSCAPE-TB-DST-Product Status 20

EOSCAPE-TB-DST-Product Description 20

Integrated Diagnostic System-Influenza A-Product Status 21

Integrated Diagnostic System-Influenza A-Product Description 21

Wave 80 Biosciences Inc, Key Employees 23

Glossary 27

Single User License:
Report can be used by individual purchaser only

Site License:
Report can be shared by unlimited users within one corporate location, e.g. a regional office

Corporate User License:
Report can be shared globally by unlimited users within the purchasing corporation e.g. all employees of a single company

To know more information on Purchase by Section, please send a mail to sales [@] kenresearch.com
 

BioGenex Laboratories Inc

Ionis Pharmaceuticals Inc

Gilead Sciences Inc

Wave 80 Biosciences Inc, Product, Pipeline, Product Pipeline, Key Pipeline, Products by Equipment Type, Equipment Type, Therapy Area, Products by Therapy Area, Development Stage, Products by Development Stage, Milestone, Products by Milestone, Major Products, Brands, No of Products, Device Class, Market, Territory, Product Name, Therapy Name, Trial Name, Trial, Indication, Summary, Event Type, Clinical Trial, MileStone, Product Status, Product Description, Description, Patent, Patent Details, Competitors, Key Employees, Subsidiaries, Locations, News, Events, Developments, medical devices, business description, company facts, trial phase, approval, estimated, technology, product patent details, phase, trial status, trial objective, trial design, trial site, business strategies, trends, pipeline and technology, sales strategies

select a license
Single User License
USD 750 INR 53498
Site License
USD 1,500 INR 71
Corporate User License
USD 2,250 INR 143

NEWSLETTER BY CATEGORY




Testimonials

The report was very informative and gives me an interesting view on the Indian market....

We would like to thank the entire team of Ken Research in showcasing professionalism in research and quick turnaround time. We have had multiple research reports from Ken Research. The deadline communicated for research was duly met. The research reports were covering many aspects in detail. This showcases their endeavor and care for client satisfaction and a strong understanding of the clients’ requirements. Thank you again for your help...

I appreciate their diligence and determination in customizing the research project. The data proves to be valuable and accurate. I would, in future, definitely use their services again...

I would like to thank Ken research team for meeting our report deliverables. The report is very good and we appreciate your well cooperation. ...

The research you conducted was very helpful for us and the integrity of your research approach gave us great confidence in the data. Look forward to collaborating again in future...



Ken Research Private Limited, Unit 14, Tower B3, Spaze I Tech Business Park, Sohna Road, sector 49
     Gurgaon, Haryana - 122001, India

download

Company Brochure

Engage with Us

sales [@] kenresearch.com